Tango Therapeutics Inc. is a cutting-edge biotechnology company that focuses on developing novel therapies for cancer treatment. Leveraging advanced technologies like CRISPR and high-throughput sequencing, Tango Therapeutics aims to identify and target genomic vulnerabilities in cancer cells. Their innovative approach holds great promise for personalized medicine and has the potential to revolutionize cancer treatment.